Yumanity Therapeutics Financial Health

How is Yumanity Therapeutics's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: YMTX's short term assets ($14.5M) exceed its short term liabilities ($7.5M).

Long Term Liabilities: YMTX has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: YMTX has more cash than its total debt.

Reducing Debt: Insufficient data to determine if YMTX's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: YMTX has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: YMTX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 20.4% each year


Discover healthy companies